Schedule: Live Sessions


Preview the Sessions That Took Place Live at CHEST 2020

All live session recordings are now available for CHEST 2020 registrants through the “Live Sessions” section of CHEST 2020 lobby. 

Please note:
This agenda only shows the live CHEST 2020 sessions.
View the CHEST 2020 On Demand sessions.

Loading Events

« All Events

  • This event has passed.

Advanced Pulmonary Sarcoidosis: Closing the Gap to Better Management

October 18, 2020 @ 7:30 am - 8:30 am CDT

Advanced pulmonary sarcoidosis (APS) occurs in approximately 5% of sarcoidosis patients, and it accounts for most of the mortality, morbidity, and healthcare use. New and emerging advances can aid clinicians in managing the complications and pathophysiologic processes of APS. These include the use of inflammatory markers, new insights into sarcoidosis-associated pulmonary fibrosis and pulmonary hypertension, infectious complications, and lung transplantation. APS would be presented with a focus on gaps in current knowledge, recent advances, and future research and clinical directions. The goal is to provide participants with evidence-based strategies to assist in better management of APS.

Learning Objectives:

  • Understand the importance of advanced pulmonary sarcoidosis.
  • Discuss a holistic approach to the management of patients with APS.


Start End
7:30 AM 7:45 AM Other Management Modalities, Including Lung Transplantation, and Closing With a Holistic Approach to APS and Panel Q&A
Rohit Gupta, MBBS, FCCP
7:45 AM 8:00 AN APS, Assessment of Inflammatory Disease, and Role of Immunosuppressive Therapy
W. James
8:00 AM 8:15 AM Screening and Management of Sarcoidosis-Associated Pulmonary Hypertension
Robert Baughman, MD, FCCP
8:15 AM 8:30 AM Airway Disease and Infectious Complications in APS
Marc Judson, MD, FCCP

Moderator: Daniel Ouellette, MD, MS, FCCP

Session ID: 24215

Keywords: Case-based Discussion Session, Diffuse Lung Disease, Popular


October 18, 2020
7:30 am - 8:30 am CDT
Event Categories:

The CHEST 2020 schedule is subject to change.